Global Fibrinogen Concentrates Market Size By Product (Animal Fibrinogen Concentrates, Human Fibrinogen Concentrate), By Application (Congenital Fibrinogen Deficiency, Surgical Procedures), By Geographic Scope And Forecast

Fibrinogen Concentrates Market Size And Forecast

Fibrinogen Concentrates Market size was valued at USD 3.11 Billion in 2024 and is projected to reach USD 4.63 Billion by 2032, growing at a CAGR of 5.64% during the forecast period 2026-2032.

The Fibrinogen Concentrates Market is expected to show considerable growth owing to increasing blood-related disorders among people and growing acceptance of people for Fibrinogen Concentrate. The Global Fibrinogen Concentrates Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Fibrinogen Concentrates Market Definition

Fibrinogen is a glycoprotein present in the blood plasma and this is produced by the liver. Fibrinogen is present in the vertebrates which helps in the formation of a blood clot, sometimes blood clot is formed inside the blood vessels because of a low level of fibrinogen which leads to thrombosis and this interrupts the normal blood flow through the circulatory system. It is also helpful for making medicines for the disease-related blood. Thrombosis is an infrequent bleeding disorder that can be characterized by mild to critical forms of bleeding. The three forms of fibrinogen deficiency are hypofibrinogenemia, afibrinogenemia, and dysfibrinogenemia. When the patient is heavily bleeding the fibrinogen concentration enhances the whole blood clot rigidness and decreases the postoperative transfusion requirements.

Global Fibrinogen Concentrates Market Overview

In this competitive world, there is increasing stress among the people due to changes in their lifestyle as a result of this there is an increase in blood-related disorders, Congenital Fibrinogen is estimated to hold the largest share of this market which results in a better occurrence of hemophilia and better fibrinogen products. Increasing the use of fibrinogen concentrates for patients with the disease-related to bleeding such as congenital deficiencies is the primary factor driving the growth of this market. Nowadays people are more aware of their health and consider health their first priority is another important factor driving the growth of this market.

Presently, instead of traditional fibrinogen sources including frozen plasma or cryoprecipitate, Fibrinogen Concentrate is broadly being accepted by the people along with the firms. The Fibrinogen Concentrates Market is increasing due to the growing patient population and use of various surgical procedures which has led to the increased demand for Fibrinogen. Moreover, The Fibrinogen concentrates are being utilized to prepare anti-coagulates which are used in the treatment of congenital afibrinogenemia, dysfibrinogenemia, hypofibrinogenemia, and others.

Global Fibrinogen Concentrates Market: Segmentation Analysis

The Global Fibrinogen Concentrates Market is Segmented on the basis of Product, Application, and Geography.

Fibrinogen Concentrates Market, By Product

• Animal Fibrinogen Concentrates
• Human Fibrinogen Concentrates

Based on Product, the market is segmented into Animal Fibrinogen Concentrates and Human Fibrinogen Concentrate. Human Fibrinogen Concentrate is estimated to hold the largest share of this segment during the forecasted period due to the increasing requirement for fibrinogen concentrate to treat bleeding disorders and congenital coagulation deficiencies.

Fibrinogen Concentrates Market, By Application

• Congenital Fibrinogen Deficiency
• Surgical Procedures
• ased on Application, the market is segmented into Congenital Fibrinogen Deficiency and Surgical Procedures. Congenital Fibrinogen is estimated to show the highest growth during the forecasted period owing to high incidences of hemophilia and increasing bleeding disorders among people. The safety proven by fibrinogen concentrates and advancements in fibrinogen products has also led to the growth of this segment in the Fibrinogen Concentrates Market.

Fibrinogen Concentrates Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of regional analysis, the Global Fibrinogen Concentrates Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is estimated to hold the largest share of this market because of the increasing burden of bleeding disorders and growing geriatric population and acquired hemophilia which is a rare autoimmune disorder is foremost in the geriatric population and a disease called Von Willebrand is one of the most common bleeding disorder which affects almost 1% of the population every year in the United States. These are the major factors contributing to the growth of the Fibrinogen Concentrates Market in this region.

Key Players

The "Global Fibrinogen Concentrates Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are CSL Behring, LFB Group, ProFibix BV, Baxter International Inc., Hualan Biological Engineering, Harbin Pacific Biopharmaceutical Co. Ltd, Green Cross Limited, and Shanghai Xinxing Medicine Co. Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• December 2021 - LFB plasma which is a part of LFB Group announced its acquisition of Immuno Tek Bio Centre in Florence, South California. LFB Group is a global biopharmaceutical company that develops and provides plasma-derived and recombinant products through its innovative technologies.
• January 2022 - GC Cell and Rivaara Immune Private Limited announced that they are about to enter into an exclusive licensing agreement, Rivaara Immune has agreed to develop and commercialize Immunecell-LC.